Ingenovis Health Inc. - S&P Global Ratings’ Credit Research

Ingenovis Health Inc.

Ingenovis Health Inc. - S&P Global Ratings’ Credit Research
Ingenovis Health Inc.
Published Aug 05, 2022
7 pages (2899 words) — Published Aug 05, 2022
Price US$ 500.00  |  Buy this Report Now

About This Report

  
Abstract:

Overview Key strengths Key risks Top 4 provider of traditional travel nurse staffing and a leader in rapid response and labor dispute staffing. More modest scale than competitors and a concentration in the highly fragmented and competitive nurse and allied staffing industry. Top 5 provider in the Locum Tenens marketplace through its acquisition of VISTA. Expectation for ongoing debt-financed acquisitions. Lack of a direct exposure to government or insurance payers limits reimbursement risk. Private equity ownership will likely result in aggressive financial policies. Strong operating margins and positive free cash flow generation. The company operates on a modest scale relative to its peers with about $1.8 billion of estimated revenue in 2022, which is up from about $1.4 billion in

  
Brief Excerpt:

...Ingenovis Health Inc. has modest scale and a concentration in the highly fragmented and competitive nurse and allied staffing industry. The company operates on a modest scale relative to its peers with about $1.8 billion of estimated revenue in 2022, which is up from about $1.4 billion in 2021. Ingenovis provides staffing through its direct channels to hospitals or health care systems and as a partner to managed service providers (MSPs), including larger health care staffing players such as AMN Healthcare, Medical Solutions, and AYA Healthcare. The company generates about 55% of its revenue from MSP channels and about 45% from its direct...

  
Report Type:

Full Report

Ticker
1945875D
Issuer
Sector
Global Issuers
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Ingenovis Health Inc." Aug 05, 2022. Alacra Store. May 22, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Ingenovis-Health-Inc-2876221>
  
APA:
S&P Global Ratings’ Credit Research. (). Ingenovis Health Inc. Aug 05, 2022. New York, NY: Alacra Store. Retrieved May 22, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Ingenovis-Health-Inc-2876221>
  
US$ 500.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.